Skip to main content
Clinical Trials/CTRI/2015/10/006257
CTRI/2015/10/006257
Completed
Phase 4

A Randomised Controlled Trial to compare the efficacy and safety of Alternate day Vs. Daily Levamisole in Frequently Relapsing and Steroid Dependent Nephrotic Syndrome - LEV/FRNS-SDNS

Dr Sushmita Banerjee0 sites196 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Sushmita Banerjee
Enrollment
196
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sushmita Banerjee

Eligibility Criteria

Inclusion Criteria

  • Patients with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome attending outpatients’ clinic with a relapse. All patients should have normal blood pressure, creatinine, C3 and ANA and be Hep.BsAg. negative.

Exclusion Criteria

  • Secondary nephrotic syndromes, steroid resistant nephrotic syndrome, any active infection, and patients who have received previous therapy with Mycophenolate mofetil, Cyclosporine A or Tacrolimus.

Outcomes

Primary Outcomes

Not specified

Similar Trials